Physician
Kleynberg Medical Clinic INC
Kleynberg Medical Clinic INC was paid $3.21M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoKLEYNBERG MEDICAL CLINIC INC
LOS ANGELES, CA 90048
LOS ANGELES, CA 90048
33aNPI1568570109assigned 08/25/2006
33bProvider typeHematology & Oncology Physician
28Total paid$3.21M
24GClaims239,587
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#8 of 180
Median peer was paid$26K
This provider vs. median125×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,464 | $567K | |
| 2019 | 27,397 | $650K | |
| 2020 | 34,500 | $550K | |
| 2021 | 31,965 | $430K | |
| 2022 | 27,689 | $343K | |
| 2023 | 42,296 | $426K | |
| 2024incomplete | 35,276 | $243K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 21,537 | 6,724 | $931K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 13% | 19,999 | 6,030 | $406K |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 25,457 | 7,140 | $401K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 11% | 11,751 | 3,413 | $355K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.5% | 11,004 | 3,255 | $178K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.5% | 4,806 | 1,079 | $144K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 5,273 | 4,461 | $124K |
| 96367 | 3.7% | 9,200 | 3,358 | $120K | |
| J3490 | Unclassified drugs | 2.8% | 7,990 | 2,219 | $89K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 10,778 | 4,641 | $80K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 17,911 | 6,974 | $62K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.5% | 3,019 | 598 | $49K |
24 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.2% | 5,594 | $39K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 747 | $39K |
| 99000 | <1% | 12,831 | $32K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 822 | $31K |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 8,468 | $30K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 27,585 | $28K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 23,389 | $19K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,460 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 718 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 178 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 295 | $7K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 83 | $6K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 28 | $5K |
| S0028 | Injection, famotidine, 20 mg | <1% | 7,771 | $3K |
| 99195 | <1% | 257 | $2K | |
| 85027 | <1% | 223 | $226.26 | |
| 96415 | <1% | 18 | $214.89 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 19 | $208.70 |
| J1750 | Injection, iron dextran, 50 mg | <1% | 26 | $195.14 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 273 | $188.79 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 19 | $12.37 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 17 | $0.00 |
| 1126F | 0% | 20 | $0.00 | |
| 1036F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKLEYNBERG, LEONID (CEO / PRESIDENT)